Motley Fool Asset Management’s ResMed RMD Stock Holding History

Motley Fool Asset Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.98M	Sell	13,280 -1,899	-13%	-$473K	0.13%	128
2025 Q4	$3.66M	Buy	15,179 +3,375	+29%	+$863K	0.14%	127
2025 Q3	$3.23M	Buy	11,804 +2,447	+26%	+$668K	0.13%	128
2025 Q2	$2.41M	Buy	9,357 +753	+9%	+$180K	0.11%	138
2025 Q1	$1.93M	Buy	8,604 +762	+10%	+$178K	0.11%	138
2024 Q4	$1.79M	Buy	7,842 +1,021	+15%	+$246K	0.09%	146
2024 Q3	$1.63M	Buy	6,821 +397	+6%	+$88.7K	0.1%	142
2024 Q2	$1.2M	Buy	6,424 +1,474	+30%	+$299K	0.08%	152
2024 Q1	$980K	Buy	4,950 +553	+13%	+$101K	0.06%	161
2023 Q4	$756K	Buy	4,397 +198	+5%	+$30.4K	0.06%	165
2023 Q3	$621K	Sell	4,199 -64,908	-94%	-$11.7M	0.05%	165
2023 Q2	$15.1M	Sell	69,107 -2,031	-3%	-$453K	1.34%	17
2023 Q1	$15.6M	Sell	71,138 -2,411	-3%	-$523K	1.72%	14
2022 Q4	$15.3M	Sell	73,549 -2,806	-4%	-$616K	1.73%	12
2022 Q3	$16.7M	Sell	76,355 -1,835	-2%	-$418K	1.64%	14
2022 Q2	$16.9M	Sell	78,190 -3,828	-5%	-$815K	1.59%	12
2022 Q1	$19.9M	Sell	82,018 -4,031	-5%	-$975K	1.46%	16
2021 Q4	$22.4M	Sell	86,049 -295	-0.3%	-$76.5K	1.43%	17
2021 Q3	$22.8M	Buy	86,344 +321	+0.4%	+$87.8K	1.48%	18
2021 Q2	$21.2M	Buy	86,023 +3,523	+4%	+$741K	1.4%	20
2021 Q1	$16M	Sell	82,500 -21,368	-21%	-$4.28M	1.15%	28
2020 Q4	$22.1M	Sell	103,868 -31,797	-23%	-$6.34M	1.65%	18
2020 Q3	$23.3M	Buy	135,665 +408	+0.3%	+$75.3K	2.07%	12
2020 Q2	$26M	Buy	135,257 +105	+0.1%	+$17.2K	2.6%	10
2020 Q1	$19.9M	Sell	135,152 -17,073	-11%	-$2.72M	2.58%	9
2019 Q4	$23.6M	Sell	152,225 -51,186	-25%	-$7.38M	2.53%	9
2019 Q3	$27.5M	Sell	203,411 -21	-0%	-$2.75K	3.2%	4
2019 Q2	$24.8M	Buy	203,432 +298	+0.1%	+$33K	2.77%	6
2019 Q1	$21.1M	Buy	203,134 +294	+0.1%	+$30.3K	2.44%	8
2018 Q4	$23.1M	Buy	202,840 +54	+0%	+$5.79K	3.23%	2
2018 Q3	$23.4M	Buy	202,786 +264	+0.1%	+$28.9K	2.84%	7
2018 Q2	$21M	Buy	202,522 +1,522	+0.8%	+$154K	2.81%	5
2018 Q1	$19.8M	Hold	201,000	–	–	2.78%	6
2017 Q4	$17M	Hold	201,000	–	–	3.68%	4
2017 Q3	$15.5M	Hold	201,000	–	–	3.1%	6
2017 Q2	$15.7M	Hold	201,000	–	–	3.24%	6
2017 Q1	$14.5M	Buy	201,000 +121,000	+151%	+$8.36M	3.12%	6
2016 Q4	$4.96M	Buy	+80,000	New	+$4.9M	1.1%	39

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Motley Fool Asset Management's RMD Position: Q1 2026 in Review

Motley Fool Asset Management reduced its ResMed (RMD) stake by 13% in Q1 2026, selling an estimated $473K and leaving 13,280 shares worth $2.98M. The position accounts for 0.13% of the portfolio, ranked #128.

Motley Fool Asset Management first reported a position in RMD in Q4 2016 and has held it in 38 quarters since. The position peaked at $27.5M in Q3 2019. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

Motley Fool Asset Management held 13,280 shares of ResMed worth $2.98M as of Q1 2026.
Motley Fool Asset Management sold 1,899 ResMed shares in Q1 2026, an estimated $473K.
ResMed made up 0.13% of Motley Fool Asset Management's portfolio in Q1 2026, its #128 holding.
Motley Fool Asset Management first reported a position in ResMed in Q4 2016 and has held it in 38 quarters since.
Motley Fool Asset Management's ResMed position peaked at $27.5M in Q3 2019.
938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Motley Fool Asset Management's 13F filing for Q1 2026, filed 12 May 2026.